Infectious Diseases Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Infect Control Hosp Epidemiol. 2012 Sep;33(9):869-74. doi: 10.1086/667378. Epub 2012 Jul 24.
The success of central line-associated bloodstream infection (CLABSI) prevention programs in intensive care units (ICUs) has led to the expansion of surveillance at many hospitals. We sought to compare non-ICU CLABSI (nCLABSI) rates with national reports and describe methods of surveillance at several participating US institutions.
An electronic survey of several medical centers about infection surveillance practices and rate data for non-ICU patients.
Ten tertiary care hospitals.
In March 2011, a survey was sent to 10 medical centers. The survey consisted of 12 questions regarding demographics and CLABSI surveillance methodology for non-ICU patients at each center. Participants were also asked to provide available rate and device utilization data.
Hospitals ranged in size from 238 to 1,400 total beds (median, 815). All hospitals reported using Centers for Disease Control and Prevention (CDC) definitions. Denominators were collected by different means: counting patients with central lines every day (5 hospitals), indirectly estimating on the basis of electronic orders ([Formula: see text]), or another automated method ([Formula: see text]). Rates of nCLABSI ranged from 0.2 to 4.2 infections per 1,000 catheter-days (median, 2.5). The national rate reported by the CDC using 2009 data from the National Healthcare Surveillance Network was 1.14 infections per 1,000 catheter-days.
Only 2 hospitals were below the pooled CLABSI rate for inpatient wards; all others exceeded this rate. Possible explanations include differences in average central line utilization or hospital size in the impact of certain clinical risk factors notably absent from the definition and in interpretation and reporting practices. Further investigation is necessary to determine whether the national benchmarks are low or whether the hospitals surveyed here represent a selection of outliers.
重症监护病房(ICU)中中心静脉相关血流感染(CLABSI)预防计划的成功,促使许多医院扩大了监测范围。我们旨在比较非 ICU 中心静脉置管相关血流感染(nCLABSI)发生率与全国报告,并描述几家参与的美国机构的监测方法。
对几家医疗中心进行电子调查,了解感染监测实践和非 ICU 患者的感染率数据。
10 家三级护理医院。
2011 年 3 月,向 10 家医疗中心发送了一份调查问卷。该调查问卷由 12 个问题组成,涉及每家中心非 ICU 患者的人口统计学数据和 CLABSI 监测方法。参与者还被要求提供可用的感染率和器械使用数据。
医院的床位数从 238 张到 1400 张不等(中位数为 815 张)。所有医院均报告使用疾病预防控制中心(CDC)的定义。使用不同的方法收集分母:每天计算带有中心静脉置管的患者数量(5 家医院),根据电子医嘱间接估计[公式:见正文],或使用其他自动化方法[公式:见正文]。nCLABSI 的感染率从每 1000 个导管日 0.2 例到 4.2 例不等(中位数为 2.5 例)。CDC 使用 2009 年国家医疗保健监测网络的数据报告的全国感染率为每 1000 个导管日 1.14 例。
只有 2 家医院的 nCLABSI 感染率低于住院病房的汇总感染率,其他医院均高于该感染率。可能的解释包括平均中心静脉置管使用率或医院规模的差异,某些临床危险因素的影响,这些因素明显未包含在定义中,以及在解释和报告实践中的差异。需要进一步调查以确定全国基准值是否较低,或者这里调查的医院是否代表了某些异常值的选择。